A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypesHAEMATOLOGICAIF7.92024-07-180OAAI
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AMLCELL DEATH & DISEASEIF9.62023-11-230OAAI
A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment DeterminantsHEMASPHEREIF14.62023-04-013OAAI
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphomaHEMATOLOGICAL ONCOLOGYIF3.92022-08-099OAAI
uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patientsJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-05-1027OAAI
Examining the Relationship between Circulating CD4-CD8-Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic MelanomaCELLSIF5.22021-02-169OAAI
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related StormFRONTIERS IN ONCOLOGYIF3.32020-12-146OAAI
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanomaJOURNAL OF TRANSLATIONAL MEDICINEIF7.52020-12-1012OAAI
The Tumor Microenvironment of DLBCL in the Computational EraFRONTIERS IN ONCOLOGYIF3.32020-03-3131OAAI